Category Archives: Public Policy

Latest From Public Policy

HHS Requests Public Comment on Draft Report on Gene Patents and Licensing Practices and Their Impact on Patient Access to Genetic Tests

HHS Requests Public Comment on Draft Report on Gene Patents and Licensing Practices and Their Impact on Patient Access to Genetic Tests.

Patently BIOtech  |  Leave a comment  |  Email This Post

Burrill Report’s interview with BIO’s President & CEO

Check out the new podcast on patent reform from Danny Levine of Burrill & Company at the Burrill Report blog.

Patently BIOtech  |  Leave a comment  |  Email This Post
Tags:

Patent reform and Re-examination

Patent reform legislation was introduced in the House and Senate last week. Tell BIO what you think of the expansion of re-examination proceedings.

Patently BIOtech  |  Leave a comment  |  Email This Post
Tags: ,

Tomorrow’s Senate hearing on Patent Reform

Tomorrow morning, the Senate Judiciary Committee will hold its first 2009 hearing on patent reform. If you have a minute, learn about past legislative efforts by visiting http://www.bio.org/ip/domestic/. Read the 5 Fact Sheets about last year’s legislation and take our poll:    [polldaddy poll=1439462]   To attend the hearing here in DC, or watch the webcast, visit http://www.judiciary.senate.gov/hearings/hearing.cfm?id=3701 for more information.

Patently BIOtech  |  Leave a comment  |  Email This Post
Tags: ,

BIO President & CEO James Greenwood Hosts Media Briefing

Take a look at a recent post at one of PatentlyBIOtech’s sister blogs: www.biotech-now.org. Last week, BIO’s President & CEO James Greenwood discussed patent reform, as well as other critical areas of legislative activity, impacting biotechnology researchers and companies in the United States. Visit Biotech Now and download or listen to the podcast: http://biotech-now.org/2009/03/06/bios-jim-greenwood-briefs-media-on-biotech-issues/.  

Patently BIOtech  |  Leave a comment  |  Email This Post
Tags: